Clinica Baviera, SA (ES:CBAV)
BME:CBAV
CBAV Stock Chart & Stats
€47.30
€0.20(0.61%)
At close: 4:00 PM EST
€47.30
€0.20(0.61%)
Day’s Range― - ―
52-Week Range€29.70 - €56.60
Previous CloseN/A
Volume285.00
Average Volume (3M)2.20K
Market Cap
€780.94M
Enterprise Value€785.82M
Total Cash (Recent Filing)€50.32M
Total Debt (Recent Filing)€69.16M
Price to Earnings (P/E)15.3
Beta0.54
Next Earnings
Jul 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.31%
Share Statistics
EPS (TTM)0.81
Shares Outstanding16,307,580
10 Day Avg. Volume2,444
30 Day Avg. Volume2,202
Financial Highlights & Ratios
PEG Ratio4.33
Price to Book (P/B)7.52
Price to Sales (P/S)2.74
P/FCF Ratio17.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.86
Revenue Forecast (FY)€323.25M
Bulls Say, Bears Say
Bulls Say
Specialized Clinic NetworkClinica Baviera's focused network model centers on elective refractive and broader ophthalmic services, producing fee-based revenues across diagnosis, surgery and follow-up care. That patient-pathway capture supports durable per-patient revenue, cross-selling and stable clinic utilization over time.
Consistent Multi-year GrowthSustained revenue and earnings expansion over multiple years (2021–2025) demonstrates persistent market demand and operational scalability. This trend supports reinvestment in capacity and services and provides a stronger baseline for forecasting medium-term cash flows and margin sustainability.
Solid Operating Cash GenerationConsistently positive operating cash flow—often above reported net income—indicates high earnings quality and reliable internal funding. Persistent cash generation underpins capacity to fund capex, service debt, and support dividends or share buybacks without immediate external financing in normal conditions.
Bears Say
Rising Debt TrendAn uptick in leverage into 2024–2025 reduces financial flexibility and raises sensitivity to slower growth or higher rates. Higher debt servicing obligations can limit discretionary investment, increase refinancing risk, and constrain strategic options if operating performance weakens over the next several quarters.
Free Cash Flow VolatilityVolatile free cash flow and a sharp 2025 drop—despite solid operating cash flow—suggest rising capex or working-capital needs. That variability can strain payout capacity and may force external funding for growth or operations, increasing financing cost risk and limiting stable shareholder returns.
Slower Growth And Margin AnomalyA slowdown in 2025 growth combined with an anomalous 2024 gross-profit spike raises questions on sustainability of margins. If part of prior margin strength was one-off, forward earnings and margin forecasts become less reliable, increasing execution risk for medium-term profitability targets.
Clinica Baviera News
CBAV FAQ
What was Clinica Baviera, SA’s price range in the past 12 months?
Clinica Baviera, SA lowest stock price was €29.70 and its highest was €56.60 in the past 12 months.
What is Clinica Baviera, SA’s market cap?
Clinica Baviera, SA’s market cap is €780.94M.
When is Clinica Baviera, SA’s upcoming earnings report date?
Clinica Baviera, SA’s upcoming earnings report date is Jul 28, 2026 which is in 118 days.
How were Clinica Baviera, SA’s earnings last quarter?
Clinica Baviera, SA released its earnings results on Mar 04, 2026. The company reported €0.813 earnings per share for the quarter, beating the consensus estimate of N/A by €0.813.
Is Clinica Baviera, SA overvalued?
According to Wall Street analysts Clinica Baviera, SA’s price is currently Overvalued.
Does Clinica Baviera, SA pay dividends?
Clinica Baviera, SA pays a Annually dividend of €1.57 which represents an annual dividend yield of 3.31%. See more information on Clinica Baviera, SA dividends here
What is Clinica Baviera, SA’s EPS estimate?
Clinica Baviera, SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinica Baviera, SA have?
Clinica Baviera, SA has 16,307,580 shares outstanding.
What happened to Clinica Baviera, SA’s price movement after its last earnings report?
Clinica Baviera, SA reported an EPS of €0.813 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.789%.
Which hedge fund is a major shareholder of Clinica Baviera, SA?
Currently, no hedge funds are holding shares in ES:CBAV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Clinica Baviera, SA
Clinica Baviera (CBAV) is a leading provider of ophthalmological services in Spain and several other countries, specializing in vision correction procedures such as LASIK and cataract surgery. The clinic operates a network of medical centers equipped with advanced technology and staffed by highly trained professionals to deliver quality eye care. In addition to surgical interventions, Clinica Baviera offers comprehensive eye examinations, diagnostic services, and post-operative care, focusing on improving patients' quality of life through enhanced vision.
Technical Analysis
Options Prices
Currently, No data available
---